133 related articles for article (PubMed ID: 10658365)
1. Mucocutaneous infections in hematological malignancies.
Grudeva-Popova J; Goranov S
Folia Med (Plovdiv); 1999; 41(3):40-4. PubMed ID: 10658365
[TBL] [Abstract][Full Text] [Related]
2. Surgical complications in hematological malignancies.
Nenova I; Grudeva-Popova J; Dimov R; Chapkunov A; Mihailov H
Folia Med (Plovdiv); 1999; 41(2):16-21. PubMed ID: 10534908
[TBL] [Abstract][Full Text] [Related]
3. [Skin symptoms in malignant hemopathies].
Grudeva-Popova J
Ter Arkh; 2000; 72(10):68-70. PubMed ID: 11220883
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
Böhme A; Karthaus M; Hoelzer D
Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
[TBL] [Abstract][Full Text] [Related]
5. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
6. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
[TBL] [Abstract][Full Text] [Related]
7. Oral manifestations associated with neutropenia in Syrian patients diagnosed with hematological malignancies and undergoing chemotherapy: A cross-sectional study.
Al Beesh FA; Martini N; Suleiman S; Aljoujou A
Medicine (Baltimore); 2024 Jan; 103(2):e36780. PubMed ID: 38215147
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for prophylaxis of viral infections in patients with hematological malignancies.
Cheuk DK; Chiang AK; Lee TL; Chan GC; Ha SY
Cochrane Database Syst Rev; 2011 Mar; (3):CD006505. PubMed ID: 21412895
[TBL] [Abstract][Full Text] [Related]
9. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
Svensson T; Lundström KL; Höglund M; Cherif H
Ups J Med Sci; 2017 Mar; 122(1):56-60. PubMed ID: 27739337
[TBL] [Abstract][Full Text] [Related]
10. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
García-Ruiz JC; Pontón J
Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
[No Abstract] [Full Text] [Related]
11. Antifungal prophylaxis with low doses fluconazole in patients with hematological malignancies.
Goranov S; Spasov E; Grudeva-Popova J; Vakrilov V
Folia Med (Plovdiv); 1999; 41(4):68-72. PubMed ID: 10786208
[TBL] [Abstract][Full Text] [Related]
12. Infections in hematological malignancies.
Khayr W; Haddad RY; Noor SA
Dis Mon; 2012 Apr; 58(4):239-49. PubMed ID: 22449371
[No Abstract] [Full Text] [Related]
13. Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators.
Pagano L; Tacconelli E; Tumbarello M; Laurenti L; Ortu-La Barbera E; Antinori A; Caponera S; Cauda R; Leone G
Haematologica; 1997; 82(4):415-9. PubMed ID: 9299853
[TBL] [Abstract][Full Text] [Related]
14. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
[TBL] [Abstract][Full Text] [Related]
15. The importance of risk factors for the prediction of patients with invasive pulmonary aspergillosis.
Kaya S; Gençalioğlu E; Sönmez M; Köksal I
Rev Assoc Med Bras (1992); 2017 Sep; 63(9):764-770. PubMed ID: 29239468
[TBL] [Abstract][Full Text] [Related]
16. Viral infections in patients with hematological malignancies.
Wade JC
Hematology Am Soc Hematol Educ Program; 2006; ():368-74. PubMed ID: 17124085
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents.
Kim SH; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Lee JW
Med Mycol; 2018 Feb; 56(2):197-206. PubMed ID: 28525644
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
Dewan E; Biswas D; Kakati B; Verma SK; Kotwal A; Oberoi A
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):99-105. PubMed ID: 26173033
[TBL] [Abstract][Full Text] [Related]
19. Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry.
Pérez-Sola MJ; Torre-Cisneros J; Pérez-Zafrilla B; Carmona L; Descalzo MA; Gómez-Reino JJ;
Med Clin (Barc); 2011 Nov; 137(12):533-40. PubMed ID: 21514606
[TBL] [Abstract][Full Text] [Related]
20. Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.
Conen A; Weisser M; Jörg CO; Battegay M; Trampuz A; Frei R; Christen S; Heim D; Gratwohl A; Flückiger U
Transpl Infect Dis; 2008 Feb; 10(1):66-70. PubMed ID: 17511816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
